Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase Inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT

Nom du journal : J Clin Oncol

Année : 2008

Volume : 26

Page de départ : 1664

Page de fin : 1670

Auteurs: Chia S, Gradishar W, Mauriac L, Bines J, Amant F, Federico M, Fein L, Romieu G, Buzdar A, Robertson JF, Brufsky A, Possinger K, Rennie P, Sapunar F, Lowe E, Piccart M, Lowe E,